|
|
Post by bthomas55ep on Jun 28, 2024 17:39:43 GMT -5
$70M to $75M in the quarter? Translating to $280M to $300M run rate! It's possible, probably not, but I'm pulling for it! GLTA
|
|
|
|
Post by Clement on Jun 28, 2024 21:07:15 GMT -5
|
|
|
|
Post by Clement on Jul 8, 2024 6:34:11 GMT -5
|
|
|
|
Post by ktim on Jul 8, 2024 13:23:15 GMT -5
Seems things will boil down to change in services revenue and whether management can maintain expense discipline in order to support earnings momentum.
|
|
|
|
Post by alethea on Jul 8, 2024 15:40:10 GMT -5
Seems things will boil down to change in services revenue and whether management can maintain expense discipline in order to support earnings momentum. I don't know about that. I expect to see excellent growth in Tyvaso DPI royalties. Seems like UTHR is hitting it out of the park with DPI. Those revenues are growing very strongly. And don't forget about MNKD's $50 MILLION bonus payment from UTHR if a certain level of revenue is attained. |
|
|
|
Post by prcgorman2 on Jul 8, 2024 15:54:17 GMT -5
Seems things will boil down to change in services revenue and whether management can maintain expense discipline in order to support earnings momentum. I don't know about that. I expect to see excellent growth in Tyvaso DPI royalties. Seems like UTHR is hitting it out of the park with DPI. Those revenues are growing very strongly. And don't forget about MNKD's $50 MILLION bonus payment from UTHR if a certain level of revenue is attained. If I ever knew about the bonus payment, I certainly did forget! Do you remember the terms of the $50M milestone payment? That's something definitely worth watching for. |
|
|
|
Post by alethea on Jul 8, 2024 15:59:41 GMT -5
No Gorman, I'm sorry I don't recall. But I think the term of that provision has at least a year or two to run yet.
Someone just posted in another thread that UTHR had 36% growth in Tyvaso, I think in the 1st quarter?
I think that kind of growth will likely win MNKD the bonus.
|
|
|
|
Post by cretin11 on Jul 8, 2024 16:28:06 GMT -5
I've forgotten about a $50mil bonus payment too. Surely someone here knows the deets on that. Let's grab that cash please. And of course, inquiring minds will query: "is it priced in?!"  |
|
|
|
Post by wyattdog on Jul 8, 2024 16:45:16 GMT -5
WESTLAKE VILLAGE, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that on December 27, 2023 it sold a 1% royalty in net sales of Tyvaso DPI® (treprostinil) inhalation powder in exchange for up to $200 million, including the purchase price of $150 million and an additional potential milestone payment of up to $50 million.
United Therapeutics Corporation licensed Tyvaso DPI from MannKind in 2018 and began marketing it in June 2022 for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease following U.S. FDA approval. Pursuant to a license agreement with United Therapeutics, MannKind is entitled to a 10% royalty on net sales of Tyvaso DPI, subject to certain reductions.
Under the terms of the royalty purchase agreement, Sagard Healthcare will receive royalty payments equal to 1% of the net sales of Tyvaso DPI that occur between October 1, 2023 and December 31, 2042, with MannKind retaining a 9% royalty. MannKind received a $150 million purchase payment for the 1% royalty and is entitled to receive a milestone payment as follows:
$50 million in the event that the trailing 12-month net sales of Tyvaso DPI equals or exceeds $1.9 billion by December 31, 2026; or
if the preceding milestone is not achieved, $45 million in the event that the trailing 12-month net sales of Tyvaso DPI equals or exceeds $2.3 billion by September 30, 2027.
If neither sales milestone is achieved, then (i) MannKind will not receive a milestone payment and (ii) Sagard Healthcare will not be entitled to any portion of the royalties payable to MannKind in respect of net sales of Tyvaso DPI that exceed $3.5 billion in any calendar year.
|
|
|
|
Post by alethea on Jul 8, 2024 16:48:53 GMT -5
Thank you Wyatt.
|
|
|
|
Post by ktim on Jul 9, 2024 3:43:13 GMT -5
Seems things will boil down to change in services revenue and whether management can maintain expense discipline in order to support earnings momentum. I don't know about that. I expect to see excellent growth in Tyvaso DPI royalties. Seems like UTHR is hitting it out of the park with DPI. Those revenues are growing very strongly. And don't forget about MNKD's $50 MILLION bonus payment from UTHR if a certain level of revenue is attained. Given that we are discussing Q2 results... you're saying you think MNKD achieved the milestone trigger for that bonus payment from UTHR in Q2 ? |
|
|
|
Post by bthomas55ep on Jul 9, 2024 4:12:15 GMT -5
I don't know about that. I expect to see excellent growth in Tyvaso DPI royalties. Seems like UTHR is hitting it out of the park with DPI. Those revenues are growing very strongly. And don't forget about MNKD's $50 MILLION bonus payment from UTHR if a certain level of revenue is attained. Given that we are discussing Q2 results... you're saying you think MNKD achieved the milestone trigger for that bonus payment from UTHR in Q2. From the posted release: "entitled to receive a milestone payment as follows: $50 million in the event that the trailing 12-month net sales of Tyvaso DPI equals or exceeds $1.9 billion by December 31, 2026; or if the preceding milestone is not achieved, $45 million in the event that the trailing 12-month net sales of Tyvaso DPI equals or exceeds $2.3 billion by September 30, 2027." I believe the trailing 12 month sales of Tyvaso DPI is quite a ways from the trailing 12-month net of $1.9 Billion, however, getting to $500 Million a quarter by Dec 31, 2026 seems possible at the current rate of growth. Not sure what impact LQDA would have on that should it / when it's version on Tyvaso is approved. Realistically, it appears the $50M milestone bonus is probably something for 2027 by the way I am interpreting things.. |
|
|
|
Post by letitride on Jul 9, 2024 4:56:36 GMT -5
Lets not underestimate Martines ability to exceed expectations. It could rub off on us.
|
|
|
|
Post by parrerob on Jul 9, 2024 6:15:26 GMT -5
Pay attention guys... it is not UTHR who committed the 50 m$ bonus.... it is Sagard in addition to the 150m$ already payd for the 1% royalties on Tyvaso dpi.
UTHR is involved only because they are fully driving sales so up to them if conditions included in the agreement between mnkd and sagard will be met or not.
|
|
|
|
Post by uvula on Jul 9, 2024 7:52:41 GMT -5
Please remind me who Sagard is?
|
|
